Praxis Precision's tremor-drug trial succeeds where others have failed. The stock is skyrocketing.
Praxis(US:PRAX) MarketWatch·2025-10-17 02:14Shares of Praxis Precision Medicines have hit their highest intraday level since March 2022. ...
Praxis(US:PRAX) MarketWatch·2025-10-17 02:14